Table 1 Baseline characteristicsAbbreviation: ECOG=Eastern Cooperative Oncology Group
From: A phase-1b study of everolimus plus paclitaxel in patients with small-cell lung cancer
Characteristic | Total ( n =21) |
|---|---|
Median age (years) | 59 |
Gender | |
Male | 19 (90%) |
Female | 2 (10%) |
ECOG performance status | |
1 | 14 (67%) |
2 | 7 (33%) |
Prior therapies | |
Chemotherapy | |
Two prior regimens | 15 (71%) |
Three prior regimens | 6 (29%) |
Chest radiotherapy | 6 (29%) |
Brain radiotherapy | 11 (52%) |
Prophylactic | 6 (29%) |
Treatment | 5 (24%) |
Relapsing pattern after initial therapy a | |
Sensitive | 9 (47%) |
Refractory | 12 (53%) |
Number of metastatic organ(s) | |
One | 10 (48%) |
Two | 7 (33%) |
Three or more | 4 (19%) |
